ANAPC2 (Anaphase-Promoting Complex Subunit 2) is a gene that in humans encodes a protein that is a core subunit of the Anaphase-Promoting Complex (APC/C). The APC/C is a large, multi-subunit ubiquitin ligase that plays a critical role in controlling cell cycle progression, particularly during mitosis and the G1 phase.
Function
The ANAPC2 protein, along with ANAPC11, forms the catalytic core of the APC/C. This core is responsible for the enzymatic activity of the complex, which is the ubiquitination of specific target proteins. By attaching ubiquitin tags to these proteins, the APC/C marks them for degradation by the 26S proteasome. Key substrates of the APC/C include:
- Securin: Its degradation allows for the separation of sister chromatids.
- Cyclins (e.g., mitotic cyclins such as Cyclin B): Their degradation leads to the inactivation of cyclin-dependent kinases (CDKs), driving the cell out of mitosis.
Through these actions, the APC/C ensures accurate chromosome segregation and orderly progression through the cell cycle. ANAPC2 is specifically involved in the recruitment of E2 ubiquitin-conjugating enzymes to the APC/C, a crucial step for the transfer of ubiquitin to substrates.
Structure
ANAPC2 is a relatively large protein and is part of the roughly 1.5 MDa APC/C complex, which can comprise over a dozen distinct subunits. It features a culin-like domain, characteristic of CUL family proteins, which are often found in E3 ubiquitin ligases. This structural motif is essential for its interaction with E2 ubiquitin-conjugating enzymes and the overall catalytic activity of the complex.
Clinical Significance
Given its essential role in cell cycle regulation, defects or dysregulation of ANAPC2 and the broader APC/C can have significant cellular consequences. Errors in APC/C function can lead to:
- Aneuploidy: Incorrect segregation of chromosomes, resulting in an abnormal number of chromosomes in daughter cells. This is a common feature of many cancers.
- Genomic instability: Increased rates of mutations and chromosomal aberrations.
- Uncontrolled cell proliferation: If mitotic checkpoints are bypassed due to faulty APC/C activity, cells may divide inappropriately.
While ANAPC2 itself is not typically a direct therapeutic target, understanding its role is crucial for developing therapies that target the cell cycle in diseases like cancer. Alterations in ANAPC2 expression or mutations have been observed in some human cancers, suggesting its potential contribution to oncogenesis.